Xpert® MRSA NxG

Order Now
MRSA NxG computer generated depiction.

Accurate and fast on-demand PCR testing for MRSA surveillance in 70 minutes or less

The Need

an ill woman listens to a physician
  • Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are a major cause of morbidity and mortality worldwide1
  • People with methicillin-resistant Staphylococcus aureus (MRSA) infections are 64 % more likely to die than people with drug-sensitive infections2
  • Active surveillance of inpatients for MRSA is a strategy for preventing health care-acquired infections (HAIs) by MRSA1
1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).
2 World Health Organization. (n.d.). Antimicrobial resistance. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

The Solution

a male and a female researchers scanning cepheid test cartridges
  • Xpert® MRSA NxG is a qualitative in-vitro diagnostic test intended for the detection of methicillin-resistant S. aureus (MRSA) DNA directly from nasal swabs in patients at risk for nasal colonization*
  • Quickly identify MRSA-colonized patients who may require contact precautions to aid with transmission risks and outbreak management
* Xpert MRSA NxG was compared to a Reference Culture Method. See Package Insert for additional details.

The Impact

a smiling female doctor attends an elderly woman
  • Rapid implementation of infection control measures and patient bed management1
  • Strong clinical performance compared to other commercial tests1
  • Minutes of hands-on time with results in 70 minutes on a random-access platform1
1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).

Connect To Better Outcomes

Request Info

Insights

Get More Insights